Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study.

Identifieur interne : 000431 ( Main/Corpus ); précédent : 000430; suivant : 000432

Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study.

Auteurs : Giancarlo Ceccarelli ; Cristian Borrazzo ; Claudia Pinacchio ; Letizia Santinelli ; Giuseppe Pietro Innocenti ; Eugenio Nelson Cavallari ; Luigi Celani ; Massimiliano Marazzato ; Francesco Alessandri ; Franco Ruberto ; Francesco Pugliese ; Mario Venditti ; Claudio M. Mastroianni ; Gabriella D'Ettorre

Source :

RBID : pubmed:33505983

Abstract

Background: Mounting evidence suggests SARS-CoV-2 may impact on host microbiota and gut inflammation, infecting intestinal epithelial cells. This possible link and its implications can be investigated by observing the effects of modulation of the microbial flora in patients with COVID-19. The aim of this study was to compare the rate of mortality, the need of ICU hospitalization and the length of hospitalization in patients with severe COVID-19 pneumonia who received the best available therapy (BAT) vs. patients treated with BAT and supplemented with oral bacteriotherapy. Methods: This retrospective, observational cohort study included 200 adults with severe COVID-19 pneumonia. All patients received therapeutic regimens including low molecular weight heparin plus one or more between hydroxychloroquine, azithromycin, antivirals, and Tocilizumab. Oral bacteriotherapy was used as complementary treatment. Results: Out of the 200 patients, 112 received BAT without oral bacteriotherapy, and 88 BAT with oral bacteriotherapy. Crude mortality was 22%. Eleven percent died in the group of patients treated with BAT plus oral bacteriotherapy vs. 30% subjects in the group of patients managed only with BAT (p < 0.001). By multivariate analysis, the age >65 years, CRP >41.8 mg/L, Platelets <150.000 mmc, and cardiovascular events were associated with the increased risk of mortality. Oral bacteriotherapy was an independent variable associated with a reduced risk for death. Despite large prospective trials are needed, this study highlights a possible role for oral bacteriotherapy in the management of patients hospitalized for COVID-19 pneumonia.

DOI: 10.3389/fnut.2020.613928
PubMed: 33505983
PubMed Central: PMC7829198

Links to Exploration step

pubmed:33505983

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study.</title>
<author>
<name sortKey="Ceccarelli, Giancarlo" sort="Ceccarelli, Giancarlo" uniqKey="Ceccarelli G" first="Giancarlo" last="Ceccarelli">Giancarlo Ceccarelli</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Borrazzo, Cristian" sort="Borrazzo, Cristian" uniqKey="Borrazzo C" first="Cristian" last="Borrazzo">Cristian Borrazzo</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Medical Statistics Unit, Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pinacchio, Claudia" sort="Pinacchio, Claudia" uniqKey="Pinacchio C" first="Claudia" last="Pinacchio">Claudia Pinacchio</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Santinelli, Letizia" sort="Santinelli, Letizia" uniqKey="Santinelli L" first="Letizia" last="Santinelli">Letizia Santinelli</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Innocenti, Giuseppe Pietro" sort="Innocenti, Giuseppe Pietro" uniqKey="Innocenti G" first="Giuseppe Pietro" last="Innocenti">Giuseppe Pietro Innocenti</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cavallari, Eugenio Nelson" sort="Cavallari, Eugenio Nelson" uniqKey="Cavallari E" first="Eugenio Nelson" last="Cavallari">Eugenio Nelson Cavallari</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Celani, Luigi" sort="Celani, Luigi" uniqKey="Celani L" first="Luigi" last="Celani">Luigi Celani</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Marazzato, Massimiliano" sort="Marazzato, Massimiliano" uniqKey="Marazzato M" first="Massimiliano" last="Marazzato">Massimiliano Marazzato</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Alessandri, Francesco" sort="Alessandri, Francesco" uniqKey="Alessandri F" first="Francesco" last="Alessandri">Francesco Alessandri</name>
<affiliation>
<nlm:affiliation>Department of Anaesthesia and Intensive Care, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ruberto, Franco" sort="Ruberto, Franco" uniqKey="Ruberto F" first="Franco" last="Ruberto">Franco Ruberto</name>
<affiliation>
<nlm:affiliation>Department of Anaesthesia and Intensive Care, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pugliese, Francesco" sort="Pugliese, Francesco" uniqKey="Pugliese F" first="Francesco" last="Pugliese">Francesco Pugliese</name>
<affiliation>
<nlm:affiliation>Department of Anaesthesia and Intensive Care, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Venditti, Mario" sort="Venditti, Mario" uniqKey="Venditti M" first="Mario" last="Venditti">Mario Venditti</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mastroianni, Claudio M" sort="Mastroianni, Claudio M" uniqKey="Mastroianni C" first="Claudio M" last="Mastroianni">Claudio M. Mastroianni</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="D Ettorre, Gabriella" sort="D Ettorre, Gabriella" uniqKey="D Ettorre G" first="Gabriella" last="D'Ettorre">Gabriella D'Ettorre</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33505983</idno>
<idno type="pmid">33505983</idno>
<idno type="doi">10.3389/fnut.2020.613928</idno>
<idno type="pmc">PMC7829198</idno>
<idno type="wicri:Area/Main/Corpus">000431</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000431</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study.</title>
<author>
<name sortKey="Ceccarelli, Giancarlo" sort="Ceccarelli, Giancarlo" uniqKey="Ceccarelli G" first="Giancarlo" last="Ceccarelli">Giancarlo Ceccarelli</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Borrazzo, Cristian" sort="Borrazzo, Cristian" uniqKey="Borrazzo C" first="Cristian" last="Borrazzo">Cristian Borrazzo</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Medical Statistics Unit, Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pinacchio, Claudia" sort="Pinacchio, Claudia" uniqKey="Pinacchio C" first="Claudia" last="Pinacchio">Claudia Pinacchio</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Santinelli, Letizia" sort="Santinelli, Letizia" uniqKey="Santinelli L" first="Letizia" last="Santinelli">Letizia Santinelli</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Innocenti, Giuseppe Pietro" sort="Innocenti, Giuseppe Pietro" uniqKey="Innocenti G" first="Giuseppe Pietro" last="Innocenti">Giuseppe Pietro Innocenti</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cavallari, Eugenio Nelson" sort="Cavallari, Eugenio Nelson" uniqKey="Cavallari E" first="Eugenio Nelson" last="Cavallari">Eugenio Nelson Cavallari</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Celani, Luigi" sort="Celani, Luigi" uniqKey="Celani L" first="Luigi" last="Celani">Luigi Celani</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Marazzato, Massimiliano" sort="Marazzato, Massimiliano" uniqKey="Marazzato M" first="Massimiliano" last="Marazzato">Massimiliano Marazzato</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Alessandri, Francesco" sort="Alessandri, Francesco" uniqKey="Alessandri F" first="Francesco" last="Alessandri">Francesco Alessandri</name>
<affiliation>
<nlm:affiliation>Department of Anaesthesia and Intensive Care, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ruberto, Franco" sort="Ruberto, Franco" uniqKey="Ruberto F" first="Franco" last="Ruberto">Franco Ruberto</name>
<affiliation>
<nlm:affiliation>Department of Anaesthesia and Intensive Care, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pugliese, Francesco" sort="Pugliese, Francesco" uniqKey="Pugliese F" first="Francesco" last="Pugliese">Francesco Pugliese</name>
<affiliation>
<nlm:affiliation>Department of Anaesthesia and Intensive Care, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Venditti, Mario" sort="Venditti, Mario" uniqKey="Venditti M" first="Mario" last="Venditti">Mario Venditti</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mastroianni, Claudio M" sort="Mastroianni, Claudio M" uniqKey="Mastroianni C" first="Claudio M" last="Mastroianni">Claudio M. Mastroianni</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="D Ettorre, Gabriella" sort="D Ettorre, Gabriella" uniqKey="D Ettorre G" first="Gabriella" last="D'Ettorre">Gabriella D'Ettorre</name>
<affiliation>
<nlm:affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Frontiers in nutrition</title>
<idno type="ISSN">2296-861X</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<b>Background:</b>
Mounting evidence suggests SARS-CoV-2 may impact on host microbiota and gut inflammation, infecting intestinal epithelial cells. This possible link and its implications can be investigated by observing the effects of modulation of the microbial flora in patients with COVID-19. The aim of this study was to compare the rate of mortality, the need of ICU hospitalization and the length of hospitalization in patients with severe COVID-19 pneumonia who received the best available therapy (BAT) vs. patients treated with BAT and supplemented with oral bacteriotherapy.
<b>Methods:</b>
This retrospective, observational cohort study included 200 adults with severe COVID-19 pneumonia. All patients received therapeutic regimens including low molecular weight heparin plus one or more between hydroxychloroquine, azithromycin, antivirals, and Tocilizumab. Oral bacteriotherapy was used as complementary treatment.
<b>Results:</b>
Out of the 200 patients, 112 received BAT without oral bacteriotherapy, and 88 BAT with oral bacteriotherapy. Crude mortality was 22%. Eleven percent died in the group of patients treated with BAT plus oral bacteriotherapy vs. 30% subjects in the group of patients managed only with BAT (
<i>p</i>
< 0.001). By multivariate analysis, the age >65 years, CRP >41.8 mg/L, Platelets <150.000 mmc, and cardiovascular events were associated with the increased risk of mortality. Oral bacteriotherapy was an independent variable associated with a reduced risk for death. Despite large prospective trials are needed, this study highlights a possible role for oral bacteriotherapy in the management of patients hospitalized for COVID-19 pneumonia.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">33505983</PMID>
<DateRevised>
<Year>2021</Year>
<Month>01</Month>
<Day>30</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">2296-861X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<PubDate>
<Year>2020</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in nutrition</Title>
<ISOAbbreviation>Front Nutr</ISOAbbreviation>
</Journal>
<ArticleTitle>Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study.</ArticleTitle>
<Pagination>
<MedlinePgn>613928</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fnut.2020.613928</ELocationID>
<Abstract>
<AbstractText>
<b>Background:</b>
Mounting evidence suggests SARS-CoV-2 may impact on host microbiota and gut inflammation, infecting intestinal epithelial cells. This possible link and its implications can be investigated by observing the effects of modulation of the microbial flora in patients with COVID-19. The aim of this study was to compare the rate of mortality, the need of ICU hospitalization and the length of hospitalization in patients with severe COVID-19 pneumonia who received the best available therapy (BAT) vs. patients treated with BAT and supplemented with oral bacteriotherapy.
<b>Methods:</b>
This retrospective, observational cohort study included 200 adults with severe COVID-19 pneumonia. All patients received therapeutic regimens including low molecular weight heparin plus one or more between hydroxychloroquine, azithromycin, antivirals, and Tocilizumab. Oral bacteriotherapy was used as complementary treatment.
<b>Results:</b>
Out of the 200 patients, 112 received BAT without oral bacteriotherapy, and 88 BAT with oral bacteriotherapy. Crude mortality was 22%. Eleven percent died in the group of patients treated with BAT plus oral bacteriotherapy vs. 30% subjects in the group of patients managed only with BAT (
<i>p</i>
< 0.001). By multivariate analysis, the age >65 years, CRP >41.8 mg/L, Platelets <150.000 mmc, and cardiovascular events were associated with the increased risk of mortality. Oral bacteriotherapy was an independent variable associated with a reduced risk for death. Despite large prospective trials are needed, this study highlights a possible role for oral bacteriotherapy in the management of patients hospitalized for COVID-19 pneumonia.</AbstractText>
<CopyrightInformation>Copyright © 2021 Ceccarelli, Borrazzo, Pinacchio, Santinelli, Innocenti, Cavallari, Celani, Marazzato, Alessandri, Ruberto, Pugliese, Venditti, Mastroianni and d'Ettorre.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ceccarelli</LastName>
<ForeName>Giancarlo</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Borrazzo</LastName>
<ForeName>Cristian</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Medical Statistics Unit, Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pinacchio</LastName>
<ForeName>Claudia</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Santinelli</LastName>
<ForeName>Letizia</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Innocenti</LastName>
<ForeName>Giuseppe Pietro</ForeName>
<Initials>GP</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cavallari</LastName>
<ForeName>Eugenio Nelson</ForeName>
<Initials>EN</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Celani</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marazzato</LastName>
<ForeName>Massimiliano</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alessandri</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ruberto</LastName>
<ForeName>Franco</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pugliese</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Venditti</LastName>
<ForeName>Mario</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mastroianni</LastName>
<ForeName>Claudio M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>d'Ettorre</LastName>
<ForeName>Gabriella</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2021</Year>
<Month>01</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Front Nutr</MedlineTA>
<NlmUniqueID>101642264</NlmUniqueID>
<ISSNLinking>2296-861X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">gut</Keyword>
<Keyword MajorTopicYN="N">microbiota</Keyword>
<Keyword MajorTopicYN="N">oral bacteriotherapy</Keyword>
<Keyword MajorTopicYN="N">pneumonia</Keyword>
</KeywordList>
<CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>10</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>12</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2021</Year>
<Month>1</Month>
<Day>28</Day>
<Hour>5</Hour>
<Minute>44</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2021</Year>
<Month>1</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2021</Year>
<Month>1</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33505983</ArticleId>
<ArticleId IdType="doi">10.3389/fnut.2020.613928</ArticleId>
<ArticleId IdType="pmc">PMC7829198</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Front Immunol. 2019 Jul 04;10:1551</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31333675</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2020 Jun;127:104392</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32361327</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Bone Jt Surg. 2020 Apr;8(Suppl1):226-230</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32607393</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 Dec;87(24):13795-802</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24109237</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncology. 2020;98(9):593-602</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32604093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Chronic Dis. 1987;40(5):373-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3558716</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ageing Res Rev. 2020 Sep;62:101123</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32683039</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Med (Lausanne). 2020 Jul 07;7:389</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32733907</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Sep 12;71(6):1393-1399</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32271369</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Biol Ther. 2019 Sep;19(9):949-965</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31260331</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620937170</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32600125</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Liver Int. 2020 Sep;40(9):2308</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32294285</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging (Albany NY). 2020 Jun 24;12(12):11245-11258</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32633729</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gene Ther. 2001 Oct;8(19):1499-507</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11593363</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antioxid Redox Signal. 2020 Jun 22;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32524832</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging (Albany NY). 2020 Mar 9;12(5):4641-4659</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32155131</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1997 Jan 23;336(4):243-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8995086</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thorax. 2003 May;58(5):377-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12728155</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Gastroenterol Hepatol. 2020 Aug;5(8):721-722</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32673604</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2017 Jul 1;199(1):212-223</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28566367</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 Aug 24;6:32176</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27553177</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Exp Allergy. 2016 Apr;46(4):519-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26892389</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acad Emerg Med. 2007 Aug;14(8):709-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17576773</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dig Dis. 2020;38(5):373-379</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32599601</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging (Albany NY). 2020 Jul 11;12(13):12504-12516</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32651993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circ Res. 2020 Jul 17;127(3):400-401</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32508261</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Nano. 2020 May 26;14(5):5179-5182</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32356654</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 Mar 18;6:22911</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26987602</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gastroenterology. 2020 Jul;159(1):373-375.e2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32294477</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nutrients. 2020 Jun 08;12(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32521760</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000431 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000431 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33505983
   |texte=   Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33505983" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021